Related Experiment Video
Updated: Jun 28, 2026

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection
Published on: February 17, 2015
Sera from chronic chagasic patients depress cardiac electrogenesis and conduction
P C Costa1, F S Fortes, A B Machado
1Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Brasil.
Abstract:
We report results obtained with sera from 58 chronic chagasic patients that were evaluated for effects on heart rate and atrioventricular (AV) conduction in isolated rabbit hearts and screened for the presence of muscarinic and beta-adrenergic activity. We show that sera from 26 patients decreased heart rate, while 10 increased it and 22 had no effect. Additionally, sera from 20 of the 58 patients blocked AV conduction. Muscarinic activation seems to be involved in both effects, but is not the only mechanism, since atropine did not antagonize the decrease in heart rate in 23% of sera or AV block in 40%. Sera from patients with complex arrhythmias were significantly more effective in depressing both heart rate and AV conduction. Sera that induce increases in heart rate seem to operate exclusively through beta-adrenergic activation. Two of these sera, evaluated with respect to intercellular communication in primary cultures of embryonic cardiomyocytes were able to block gap junction conductance evaluated by a dye injection technique after 24-h exposure. The mechanisms underlying this uncoupling effect are currently being investigated.
Insights
Sera from Chagas disease patients impact heart rate and atrioventricular conduction. Some sera decrease heart rate and block conduction, potentially via muscarinic pathways, while others increase heart rate through beta-adrenergic activation.
Area of Science:
- Cardiology
- Immunology
- Physiology
Background:
- Chagas disease, caused by Trypanosoma cruzi, can lead to cardiac complications.
- Autonomic nervous system dysfunction is a known feature of chronic Chagasic cardiomyopathy.
- Patient-derived antibodies may play a role in the pathogenesis of cardiac dysfunction.
Purpose of the Study:
- To investigate the effects of sera from chronic Chagasic patients on cardiac function in an isolated heart model.
- To screen these sera for muscarinic and beta-adrenergic activity.
- To explore the potential role of these sera in cardiac arrhythmias and intercellular communication.
Main Methods:
- Isolated rabbit hearts were perfused with sera from 58 chronic Chagasic patients.
- Heart rate and atrioventricular (AV) conduction were measured.
- Muscarinic and beta-adrenergic activities were screened.
- Atropine was used to assess the involvement of muscarinic pathways.
- Gap junction conductance was evaluated in cardiomyocyte cultures using dye injection.
Main Results:
- Sera from 26 patients decreased heart rate, 10 increased it, and 22 had no effect.
- Sera from 20 patients blocked AV conduction.
- Muscarinic pathways were implicated but not solely responsible for all observed effects.
- Sera causing heart rate increases acted via beta-adrenergic activation.
- Two sera blocked gap junction conductance in cardiomyocytes.
Conclusions:
- Patient sera can directly influence cardiac electrophysiology, affecting heart rate and AV conduction.
- Both inhibitory and stimulatory effects on cardiac function are mediated by specific serum components.
- Further investigation is needed to elucidate the precise mechanisms of serum-induced cardiac dysfunction and uncoupling.
More Related Videos
Related Concept Videos
Electrophysiology of Normal Cardiac Rhythm
Mechanism of Cardiac Arrhythmias
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Esophageal Achalasia

